Patients with diabete type 1 under pump
Conditions
Interventions
None listed
Sponsors
Sublin B.V.
Eligibility
Sex/Gender
Male
Age
18 Years to 64 Years
Outcome results
None listed
Proof of cOncept Study demonStrating the potential substitutIon of suBcutaneous Injection of recombinant human insulin by subLIngual administration of S.L.I.M®-Formulations in TYpe-I DIABEtic PaTiEntS
For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms
Source: EU CTIS · Data processed: Aug 25, 2026